Christophe Demaison
Vorstandsvorsitzender bei Ena Respiratory Pty Ltd.
Profil
Christophe Demaison is currently the Chief Executive Officer, MD & Director at Ena Respiratory Pty Ltd.
and a Non-Executive Director at BACE Therapeutics Pty Ltd.
He previously worked as a Non-Executive Director at Otifex Therapeutics Pty Ltd., a Scientist at Sangamo Therapeutics UK Ltd., a Business Manager at Cancer Research Technology Ltd., and a Principal at Great Ormond Street Hospital Children's Charity.
Dr. Demaison holds a doctorate degree from the University of Strasbourg.
Aktive Positionen von Christophe Demaison
| Unternehmen | Position | Beginn |
|---|---|---|
| BACE Therapeutics Pty Ltd. | Direktor/Vorstandsmitglied | - |
Ena Respiratory Pty Ltd.
 Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christophe Demaison
| Unternehmen | Position | Ende |
|---|---|---|
Great Ormond Street Hospital Children's Charity
 Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Direktor/Vorstandsmitglied | - |
Sangamo Therapeutics UK Ltd.
 Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics UK Ltd. researches and develops transcription factors in the regulation of genes. The company was founded on April 21, 1999 and is headquartered in Cheltenham, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Christophe Demaison
| University of Strasbourg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Sangamo Therapeutics UK Ltd.
Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics UK Ltd. researches and develops transcription factors in the regulation of genes. The company was founded on April 21, 1999 and is headquartered in Cheltenham, the United Kingdom. | Commercial Services |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
Great Ormond Street Hospital Children's Charity
Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Miscellaneous |
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Health Technology |
| BACE Therapeutics Pty Ltd. | |
Ena Respiratory Pty Ltd.
Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Health Technology |
